This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza
Clinical trial NCT07371650 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07371650
- Sponsor
- Traws Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2026-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.